PatentPatent Analysis

EP3564378

GLAXOSMITHKLINE BIOLOGICALS
Application Number
EP19179871A
Filing Date
May 25, 2012
Status
Granted And Under Opposition
Sep 29, 2023
Grant Date
Nov 1, 2023
External Links
Slate, Register, Google Patents
Similar Patents facing opposition

Bibliography

The patent EP3564378B1 was granted to Glaxosmithkline Biologicals on Nov 1, 2023 following the initial filing on May 25, 2012 under the application number EP19179871A . The current legal status of the patent is Granted And Under Opposition.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions filed by Competitors

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

VALNEVA AUSTRIAJul 25, 2024ADMISSIBLE

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents